These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4287801)

  • 21. [Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1979 Feb; 118(8):240-5. PubMed ID: 109213
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship of the bacteriostatic action of drugs to the number of tubercle bacilli.
    SERI I
    Acta Tuberc Pneumol Scand; 1962; 42():173-84. PubMed ID: 13988070
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies in guinea pigs on the resistance of tubercle bacilli to ethionamide].
    Janowiec M; Krakówka P
    Gruzlica; 1965 Apr; 33(4):273-6. PubMed ID: 4953732
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the instability of ethionamide resistance and on the stability of other drug resistances in tubercle bacilli (five to nine years' in vitro observations)].
    Tsukamura M; Tsukamura S
    Kekkaku; 1967 Jan; 42(1):23-7. PubMed ID: 4962455
    [No Abstract]   [Full Text] [Related]  

  • 26. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa].
    Zykov MP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):49-53. PubMed ID: 4295172
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of drug sensitivity of Mycobacterium tuberculosis by means of potassium tellurite].
    Kovalev GK
    Antibiotiki; 1969 Apr; 14(4):323-5. PubMed ID: 4977639
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the sensitivity to ethionamide, thiacetazone and isoxyl of tubercle bacilli from previously untreated patients in Tokyo.
    Fukuhara Y; Kobayashi H; Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):57-61. PubMed ID: 4097677
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 32. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 33. [Frequency of Mycobacterium tuberculosis L-form induction under the influence of cycloserine and its combinations with other drugs].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1972 Sep; 17(9):838-44. PubMed ID: 4120084
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
    Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
    Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteriostatic activity of preparations of the 2d series and criteria of the resistance to them].
    Mkrtchian SV; Afanas'eva IuP
    Probl Tuberk; 1967; 45(8):70-5. PubMed ID: 4303640
    [No Abstract]   [Full Text] [Related]  

  • 36. A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO STREPTOMYCIN, CYCLOSERINE, VIOMYCIN, AND KANAMYCIN OF TUBERCLE BACILLI FROM 100 PATIENTS NEVER TREATED WITH CYCLOSERINE, VIOMYCIN, OR KANAMYCIN.
    HOK TT; SENG TK
    Am Rev Respir Dis; 1964 Dec; 90():961-2. PubMed ID: 14233803
    [No Abstract]   [Full Text] [Related]  

  • 37. [Induction of L-forms of Mycobacterium tuberculosis under the action of ethambutol, ethionamide and their combinations with some antibiotic and tuberculostatic drugs].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1973 Feb; 18(2):144-8. PubMed ID: 4130173
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the combined activity of tuberculostatic agents on tubercle bacilli. I. Studies on the activity of thioamide of alpha-ethyl-isonicotinic acid on acid fast bacilli in vitro].
    Manowska W
    Gruzlica; 1966 Nov; 34(11):963-8. PubMed ID: 4962783
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.